IDWeek Data

New performance data presented at IDWeek 2017

Barnes-Jewish Hospital -

Analytical Performance Characteristics of the Accelerate Pheno™ system for Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia

Jason P. Burnham, Meghan A. Wallace, Brian M. Fuller, Carey-Ann D. Burnham, Marin H. Kollef

From the data
  • “The Accelerate Pheno™ system is a novel fast diagnostic with high sensitivity, specificity, positive and negative predictive values, and category agreement for antimicrobial susceptibility testing”

  • Barnes-Jewish Hospital -

    Clinical Impact of Expedited Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia Using the Accelerate Pheno™ system

    Jason P. Burnham, Meghan A. Wallace, Brian M. Fuller, Carey-Ann D. Burnham, Marin H. Kollef

    From the data
  • “The Accelerate Pheno™ system is a novel fast diagnostic that significantly reduces the time to ID and AST for GNB and ID of Candida spp. bloodstream infections, with the potential to impact clinical outcomes”

  • Jena University Hospital -

    Accelerating Time to Pathogen-adapted Antibiotic Treatment through Culture- independent Antimicrobial Susceptibility Testing in Patients suffering from Sepsis

    Matthias Karrasch

    From the data
  • “Due to the short hands-on-time, subculture-independence, and fast generation of results, this system represents a promising new diagnostic method for pathogen-adapted antibiotic treatment in selected patients”

  • Mount Sinai Hospital -

    Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ system (AXDX) for Gram-negative (GNB) Bloodstream Infections

    Nancy Matic, Barbara Willey, Bryan Gascon, Samantha Lee, Vita Koren, Salman Surangiwala, Pauline Lo, Tony Mazzulli, and Susan M. Poutanen

    From the data
  • “AXDX generated the shortest ID and AST TATs with the greatest potential to significantly shorten the time to ABX tailoring in Gram-negative bacilli bloodstream infections thereby impacting patient outcomes”

  • Mount Sinai Hospital -

    Prospective Evaluation of Accelerate Pheno™ system (AXDX) Version 1.1 for Reducing Turn-Around-Time (TAT) in Identification/ Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) from Positive Blood Cultures (+BC) using AXDX PhenoTest™ BC kits

    Barbara M. Willey, Bryan Gascon, Samantha Lee, Vita Koren, Salman Surangiwala, Aimee Paterson, Pauline Lo, Tony Mazzulli, and Susan M. Poutanen

    From the data
  • “These data suggest AXDX will substantially reduce ID/AST TAT in 83.6% of GNB bacteremia with potential to significantly improve patient outcomes”

  • Mount Sinai Hospital -

    Retrospective Evaluation of Accelerate Pheno™ system (AXDX, Version 1.1) for Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) including Carbapenemase-Producing Organisms (CPO) from Seeded Blood Culture Bottles (SBCB) Tested using AXDX PhenoTest™ BC kits

    Barbara M. Willey, Bryan Gascon, Samantha Lee, Vita Koren, Salman Surangiwala, Aimee Paterson, Pauline Lo, David A. Boyd, Michael Mulvey, Tony Mazzulli, and Susan M. Poutanen

    From the data
  • “The AXDX PhenoTest™ BC kit and Pheno™ system were extremely simple to use and provided rapid ID/AST with MIC in 86.3% seeded BC tested directly from the BacT/Alert® bottles, with ID/AST reporting at 1.3h/6.5h , respectively”

  • Northwestern Memorial Hospital -

    Impact of Accelerate Pheno™ system on Time to Antimicrobial Stewardship Intervention in Patients with Gram-Negative Blood Stream Infections

    Gerald Elliott , Michael Postelnick

    From the data
  • “Time to Antimicrobial Stewardship Intervention guided by the Accelerate Pheno™ system significantly shortened the time to potential antimicrobial optimization compared to our institution’s standard of care in patients with Gram-Negative blood stream infections.”

  • Primary Children's Hospital -

    Performance Verification of the Accelerate Pheno™ system for Rapid Identification and Antimicrobial Susceptibility Testing from Positive Blood Culture in a Pediatric Population

    Judy Daly

    From the data
  • “Implementing this system could allow laboratories to provide clinicians with actionable results much sooner, enabling them to optimize therapy earlier to improve patient outcomes”